Tag Archives: Between

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

There are no real differences between tenofovir formulations – tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) – in terms of viral suppression and bone and renal safety, according to a systematic review and meta-analysis published in AIDS. The newer formulation of the drug (TAF) only showed superiority in terms of efficacy, and then to a modest… Read More »

How to read between the lines of the healthcare data blocking debate

About a year ago, the Department of Health and Human Services first proposed rules to promote sharing and the interoperability of health data to enable patients to electronically access their health information. Many of the top industry players submitted commentary to The Office of the National Coordinator for Health Information Technology and the Centers for… Read More »